Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06867289 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Study of the Efficacy of Moderate Sedation With Intra-NAsal Dexmedetomidine Monitored by EEG MOnitoring

Study acronym: DINAMO
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary and study completion dates: Apr 8, 2026 to Apr 8, 2027v3
  2. Trial status: Not Yet Recruiting to Recruiting
    • Primary and study completion dates: Apr 1, 2026 to Apr 8, 2026
    • Start date changed from estimate of Mar 13, 2025 to Apr 8, 2025
    • Site details revised
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a prospective, monocentric diagnostic study aiming to evaluate whether a sedation score obtained by a per-procedural electroencephalogram (EEG), the PSI score, could identify patients for whom a 2 μg/kg dose of DEX would not be sufficient for the successful performance of cerebral NMRI, and who could therefore benefit from a higher dosage of DEX (4 μg/kg).
Trial Details
NCT Number NCT06867289
Lead Sponsor Centre Hospitalier Régional Metz-Thionville
Conditions
(from sponsor)		 Procedural Sedation and Analgesia, Pediatric ALL
Related terms Agnosia, Precursor Cell Lymphoblastic Leukemia-Lymphoma
Enrollment 50 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov